Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Reduce Risk of MI & Stroke in CVD Patients | Repatha® (evolocumab) |
Description | Learn about PCSK9 inhibitor Repatha® (evolocumab) and how it reduces risk of stroke and myocardial infarction in your patients with established CV disease |
Keywords | N/A |
WebSite | www.repathahcp.com |
Host IP | 52.38.137.222 |
Location | Boardman, Oregon, United States |
Site | Rank |
repatha.com | #810,811 |
praluenthcp.com | #6,917,210 |
amgensafetynetfoundation.com | #1,297,766 |
amgen.ca | #2,640,807 |
US$7,772
Last updated: Apr 12, 2020
Repathahcp.com has global traffic rank of 2,192,427. Repathahcp.com has an estimated worth of US$ 7,772, based on its estimated Ads revenue. Repathahcp.com receives approximately 1,419 unique visitors each day. Its web server is located in Boardman, Oregon, United States, with IP address 52.38.137.222. According to SiteAdvisor, repathahcp.com is safe to visit. |
Purchase/Sale Value | US$7,772 |
Daily Ads Revenue | US$4 |
Monthly Ads Revenue | US$127 |
Yearly Ads Revenue | US$1,554 |
Daily Unique Visitors | 1,419 |
Note: All traffic and earnings values are estimates. |
Global Rank | 2,192,427 |
Delta (90 Days) | 0 |
Most Popular In Country | N/A |
Country Rank | N/A |
Host | Type | TTL | Data |
repathahcp.com | A | 59 | IP: 34.209.10.117 |
repathahcp.com | A | 59 | IP: 52.38.137.222 |
repathahcp.com | MX | 299 | Priority: 20 Target: a-0018ee01.gslb.pphosted.com. |
repathahcp.com | MX | 299 | Priority: 10 Target: a-0018ee01.gslb.pphosted.com. |
repathahcp.com | NS | 21599 | Target: ns-184.awsdns-23.com. |
repathahcp.com | NS | 21599 | Target: ns-2027.awsdns-61.co.uk. |
repathahcp.com | NS | 21599 | Target: ns-765.awsdns-31.net. |
repathahcp.com | NS | 21599 | Target: ns-1123.awsdns-12.org. |
repathahcp.com | SOA | 899 | MNAME: ns-2027.awsdns-61.co.uk. RNAME: awsdns-hostmaster.amazon.com. Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 Minimum TTL: 86400 |
HTTP/1.1 301 Moved Permanently Date: Sun, 12 Apr 2020 07:14:47 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 146 Connection: keep-alive Set-Cookie: AWSALB=ASB6RnPd9IOUMYwciwowo3u+t+p8O6W4hpfAhqyUl1Pd26/FROlg81AK/JjOnaHKd+Am3sqBzUhtlAFRLwxa+HYBo9R0VzCp8iDl2rEPj7zCGUhaML4epv0/WMeQ; Expires=Sun, 19 Apr 2020 07:14:47 GMT; Path=/ Set-Cookie: AWSALBCORS=ASB6RnPd9IOUMYwciwowo3u+t+p8O6W4hpfAhqyUl1Pd26/FROlg81AK/JjOnaHKd+Am3sqBzUhtlAFRLwxa+HYBo9R0VzCp8iDl2rEPj7zCGUhaML4epv0/WMeQ; Expires=Sun, 19 Apr 2020 07:14:47 GMT; Path=/; SameSite=None Location: https://repathahcp.com/ Content-Security-Policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com X-Frame-Options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com X-Xss-Protection: 1; mode=block HTTP/2 301 date: Sun, 12 Apr 2020 07:14:48 GMT content-type: text/html; charset=UTF-8 content-length: 150 location: https://www.repathahcp.com/ set-cookie: AWSALB=X0hA7u4QVNgUuRkvDcYtS6cJ2tSJFXMcTPn38fgjUmlrbM/3y9RhsCBFbJ2ypTM4O9c4zT1Rbqjkthl4QjSf4CrC+0MeUi7rgCwmlhUu7sMUORcnEyiSWZ0G/mgL; Expires=Sun, 19 Apr 2020 07:14:48 GMT; Path=/ set-cookie: AWSALBCORS=X0hA7u4QVNgUuRkvDcYtS6cJ2tSJFXMcTPn38fgjUmlrbM/3y9RhsCBFbJ2ypTM4O9c4zT1Rbqjkthl4QjSf4CrC+0MeUi7rgCwmlhUu7sMUORcnEyiSWZ0G/mgL; Expires=Sun, 19 Apr 2020 07:14:48 GMT; Path=/; SameSite=None; Secure content-security-policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-frame-options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-xss-protection: 1; mode=block HTTP/2 200 date: Sun, 12 Apr 2020 07:14:48 GMT content-type: text/html; charset=utf-8 content-length: 92177 set-cookie: AWSALB=OAvZ5v5PJdgRL/oYxXiK/lybWllGD7fyvHTc3p/ZruMs5sPuCLHc3kp9rTroRsyqDCFtH9H5LKvu0xetktBxpd0O+nf7r5MQ1wLICw3q3gy/5n+sBVPf+C+GPq5M; Expires=Sun, 19 Apr 2020 07:14:48 GMT; Path=/ set-cookie: AWSALBCORS=OAvZ5v5PJdgRL/oYxXiK/lybWllGD7fyvHTc3p/ZruMs5sPuCLHc3kp9rTroRsyqDCFtH9H5LKvu0xetktBxpd0O+nf7r5MQ1wLICw3q3gy/5n+sBVPf+C+GPq5M; Expires=Sun, 19 Apr 2020 07:14:48 GMT; Path=/; SameSite=None; Secure cache-control: no-cache, no-store pragma: no-cache expires: -1 set-cookie: ASP.NET_SessionId=cowkgpp1nftbmzod1tkhq5ov; path=/; HttpOnly content-security-policy: frame-ancestors 'self' http://www.medscape.com https://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-frame-options: ALLOW-FROM http://www.medscape.com https://www.medscape.com https://business.facebook.com https://www.facebook.com x-xss-protection: 1; mode=block |
Domain Name: REPATHAHCP.COM Registry Domain ID: 1900849401_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2018-07-25T20:50:04Z Creation Date: 2015-02-04T23:53:37Z Registry Expiry Date: 2023-02-04T23:53:37Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS-1123.AWSDNS-12.ORG Name Server: NS-184.AWSDNS-23.COM Name Server: NS-2027.AWSDNS-61.CO.UK Name Server: NS-765.AWSDNS-31.NET DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ Domain Name: repathahcp.com Registry Domain ID: 1900849401_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-01-04T02:14:05-0800 Creation Date: 2015-02-04T15:53:37-0800 Registrar Registration Expiration Date: 2023-02-04T00:00:00-0800 Registrar: MarkMonitor, Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895770 Domain Status: clientUpdateProhibited (https://www.icann.org/epp#clientUpdateProhibited) Domain Status: clientTransferProhibited (https://www.icann.org/epp#clientTransferProhibited) Domain Status: clientDeleteProhibited (https://www.icann.org/epp#clientDeleteProhibited) Registry Registrant ID: Registrant Name: Domain Administration Registrant Organization: Amgen Inc. Registrant Street: One Amgen Center Drive, MS 28-5-A Registrant City: Thousand Oaks Registrant State/Province: CA Registrant Postal Code: 91320 Registrant Country: US Registrant Phone: +1.8054471000 Registrant Phone Ext: Registrant Fax: +1.8054998011 Registrant Fax Ext: Registrant Email: amgendomains@amgen.com Registry Admin ID: Admin Name: Domain Administration Admin Organization: Amgen Inc. Admin Street: One Amgen Center Drive, MS 28-5-A Admin City: Thousand Oaks Admin State/Province: CA Admin Postal Code: 91320 Admin Country: US Admin Phone: +1.8054471000 Admin Phone Ext: Admin Fax: +1.8054998011 Admin Fax Ext: Admin Email: amgendomains@amgen.com Registry Tech ID: Tech Name: Domain Administration Tech Organization: Amgen Inc. Tech Street: One Amgen Center Drive, MS 28-5-A Tech City: Thousand Oaks Tech State/Province: CA Tech Postal Code: 91320 Tech Country: US Tech Phone: +1.8054471000 Tech Phone Ext: Tech Fax: +1.8054998011 Tech Fax Ext: Tech Email: amgendomains@amgen.com Name Server: ns-2027.awsdns-61.co.uk Name Server: ns-184.awsdns-23.com Name Server: ns-1123.awsdns-12.org Name Server: ns-765.awsdns-31.net DNSSEC: unsigned URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/ MarkMonitor Domain Management(TM) Protecting companies and consumers in a digital world. Visit MarkMonitor at https://www.markmonitor.com Contact us at +1.8007459229 In Europe, at +44.02032062220 |